In the News

04/23/2019 12:00 AM  | Inside Sources
04/22/2019 12:00 AM  | The Washington Times
02/26/2019 12:00 AM  | The Washington Times
02/19/2019 12:00 AM  | Cancer Therapy Advisor
01/08/2019 12:00 AM  | The Washington Times
01/06/2019 12:00 AM  | RealClearHealth
12/17/2018 12:00 AM  | Morning Consult
12/04/2018 12:00 AM  | The Washington Times
11/11/2018 12:00 AM  | Echo Press
09/21/2018 12:00 AM  | Real Clear Policy
08/28/2018 12:00 AM  | Fortune
Sign Up for Our Email Newsletter

RECENT NEWS

Waiving COVID-19 Vaccine Patents: A Bad Idea and a Dangerous Precedent

Waiving COVID-19 Vaccine Patents: A Bad Idea and a Dangerous Precedent

Waiving patent protection discourages cutting-edge research investments, which in turn produce breakthrough treatments no...  Read more

'I'm hopeful for the future': Alzheimer's drug approved by FDA

'I'm hopeful for the future': Alzheimer's drug approved by FDA

Peter Pitts of CMPI and Dr. Ronald Petersen of the Mayo Clinic discuss the FDA's approval of aducanumab...  Read more

Biosimilar Strength vs. Potency: Avoiding a Regulatory Hobson’s Choice

Biosimilar Strength vs. Potency: Avoiding a Regulatory Hobson’s Choice

Biosimilars bring lower costs and greater access to the market for biological products, but FDA must determine a predicta...  Read more

DRUGWONKS BLOG